fludarabine and Blindness

fludarabine has been researched along with Blindness in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ross Reichard, R; Vaubel, RA	1
Bishop, RJ; Caruso, R; Chan, CC; Cunningham, D; Ding, X; Heller, CK; Illei, G; Pavletic, S	1

Other Studies

2 other study(ies) available for fludarabine and Blindness

Article	Year
A 56-year-old woman with blindness and mental status changes. Brain pathology (Zurich, Switzerland), 2018, Volume: 28, Issue:4 Topics: Antineoplastic Agents; Blindness; Female; Humans; Leukoencephalopathies; Mental Disorders; Middle Aged; Vidarabine	2018
Rapid vision loss associated with fludarabine administration. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:8 Topics: Antineoplastic Agents; Blindness; Brain Diseases; Electroretinography; Evoked Potentials, Visual; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Myeloablative Agonists; Retina; Retinal Diseases; Retrospective Studies; Vidarabine; Young Adult	2010

Article

Year

A 56-year-old woman with blindness and mental status changes.

Brain pathology (Zurich, Switzerland), 2018, Volume: 28, Issue:4

Topics: Antineoplastic Agents; Blindness; Female; Humans; Leukoencephalopathies; Mental Disorders; Middle Aged; Vidarabine

2018

Rapid vision loss associated with fludarabine administration.

Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:8

Topics: Antineoplastic Agents; Blindness; Brain Diseases; Electroretinography; Evoked Potentials, Visual; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Myeloablative Agonists; Retina; Retinal Diseases; Retrospective Studies; Vidarabine; Young Adult

2010